NCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
Clinical Trials
19 trialsNCT05448365 2026-02-12
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
Lo.Li.Pharma s.r.l
Phase NA Recruiting
NCT06671548 2026-02-02
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT07378098 2026-01-30
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
JW Pharmaceutical
Phase 3 Recruiting
NCT04756037 2026-01-08
SERENE
Sumitomo Pharma Switzerland GmbH
Phase 3 Active not recruiting
NCT05445167 2025-11-25
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Kissei Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT06058728 2025-09-17
Pink Orchid
AbbVie
Withdrawn
NCT07078682 2025-09-12
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Zenchi, Inc.
Phase NA Recruiting
NCT06949124 2025-09-10
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
NCT02748460 2025-09-02
Premium
PregLem SA
Completed
NCT05739123 2025-08-19
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Sumitomo Pharma Switzerland GmbH
Recruiting
NCT06969664 2025-08-19
A Trial of SHR7280 in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT05862272 2025-08-06
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Phase 3 Recruiting
NCT05739136 2025-08-01
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Sumitomo Pharma Switzerland GmbH
Active not recruiting
NCT03194646 2025-07-28
ASTEROID 6
Bayer
Phase 3 Terminated
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT05386615 2025-04-30
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
InSightec
Recruiting